Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients-Reference-Cited by-同舟云学术

Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients

Published:2021-09-06 Issue:11 Volume:96 Page:1472-1480
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Loscocco Giuseppe G.¹^ORCID,Guglielmelli Paola¹^ORCID,Gangat Naseema²^ORCID,Rossi Elena³⁴,Mannarelli Carmela¹,Betti Silvia⁴,Maccari Chiara¹,Ramundo Francesco³,Jadoon Yamna²,Gesullo Francesca¹,Ceglie Sara³,Paoli Chiara¹,Pardanani Animesh²^ORCID,De Stefano Valerio³⁴^ORCID,Tefferi Ayalew²^ORCID,Vannucchi Alessandro M.¹^ORCID

Affiliation:

1. Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero‐Universitaria Careggi University of Florence Florence Italy

2. Divisions of Hematology Mayo Clinic Rochester Minnesota USA

3. Section of Hematology, Department of Radiological and Hematological Sciences Catholic University Rome Italy

4. Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26332

Reference24 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Essential Thrombocythemia